Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi’s sarcoma in five countries across sub-Saharan Africa [PDF]
BMC Cancer, 2016 Survival after diagnosis is a fundamental concern in cancer epidemiology. In resource-rich settings, ambient clinical databases, municipal data and cancer registries make survival estimation in real-world populations relatively straightforward. In resource-poor settings, given the deficiencies in a variety of health-related data systems, it is less ...
Antoine Jaquet +23 more
openaire +9 more sources
Dermatomyositis with Kaposi’s Sarcoma in a Patient without Human Immunodeficiency Virus-1 Infection
Canadian Journal of Gastroenterology, 1991 The first case of dermatomyositis complicating cutaneous and visceral Kaposi’s sarcoma is presented in a 75-year-old man without human immunodeficiency virus infection.
Dana Liang +4 more
doaj +1 more source
Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine programme conditions in Malawi. [PDF]
, 2008 AIDS-associated Kaposi's sarcoma (KS) is the most common AIDS-related malignancy in sub-Saharan Africa, with a generally unfavourable prognosis. We report on six-month and 12-month cohort treatment outcomes of human immunodeficiency virus (HIV)-positive ...
Anthony D Harries +14 more
core +2 more sources
Rainbow Kaposi's Sarcoma-Associated Herpesvirus Revealed Heterogenic Replication with Dynamic Gene Expression. [PDF]
, 2020 Molecular mechanisms of Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation have been studied primarily by measuring the total or average activity of an infected cell population, which often consists of a mixture of both nonresponding and ...
Campbell, Mel +10 more
core
Multiple human herpesvirus-8 infection [PDF]
, 2003 In Malawian patients with Kaposi sarcoma (KS) and their relatives, we investigated nucleotide-sequence variation in human herpesvirus-8 (HHV-8) subgenomic DNA, amplified from oral and blood samples by use of polymerase chain reaction.
Beyari, MM +7 more
core +1 more source
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Journal of Experimental Medicine, 2006 Emerging evidence suggests that both human stem cells and mature stromal cells can play an important role in the development and growth of human malignancies. In contrast to these tumor-promoting properties, we observed that in an in vivo model of Kaposi'
A. Khakoo +16 more
semanticscholar +1 more source
Клинический случай ВИЧ-ассоциированной опухолевой саркомы Капоши [PDF]
, 2016 Наведено спостереження клінічного випадку ВІЛасоційованої пухлинної саркоми Капоші та сучасні уявлення щодо етіопатогенезу, клініки, діагностики і лікування саркоми Капоші.
Дюдюн, А.Д. +4 more
core +2 more sources
Diagnosis of elephantiasis nostras verrucosa as a clinical mani-festation of Kaposi's sarcoma
Medwave, 2020 Elephantiasis nostras verrucosa, a rare manifestation of Kaposi’s sarcoma, is a progressive cutaneous hypertrophy caused by chronic non-filarial lymphedema secondary to obstruction of the lymphatic system that can lead to severe disfigurement of parts of
Javier Arellano +3 more
doaj +1 more source
The zebrafish xenograft platform-A novel tool for modeling KSHV-associated diseases [PDF]
, 2019 Kaposi\u27s sarcoma associated-herpesvirus (KSHV, also known as human herpesvirus-8) is a gammaherpesvirus that establishes life-long infection in human B lymphocytes.
Berman, Jason N +12 more
core +2 more sources
Disseminated HIV-Associated Kaposi’s Sarcoma With High CD4 Cell Count And Low Viral Load
Galicia Clínica, 2017 Kaposi’s sarcoma is considered an acquired immunodeficiency syndrome-defining illness and is caused by human herpesvirus 8. It has been associated with patients infected with human immunodeficiency virus (HIV) who have CD4 T lymphocytes
Diana Pereira Anjos +3 more
doaj +1 more source